Multi-institutional review of adverse events associated with irreversible electroporation in the treatment of locally advanced pancreatic cancer

医学 不可逆电穿孔 不利影响 电穿孔 胰腺癌 重症监护医学 内科学 肿瘤科 癌症 生物化学 化学 基因
作者
Kyle R Stephens,Prejesh Philips,Michael E. Egger,Charles R. Scoggins,Kelly M. McMasters,Robert C.G. Martin
出处
期刊:Surgery [Elsevier BV]
卷期号:175 (3): 704-711 被引量:11
标识
DOI:10.1016/j.surg.2023.08.042
摘要

Irreversible electroporation is a novel approach for treating locally advanced pancreatic adenocarcinoma. However, this ablative technique is not without risk and has the potential to precipitate adverse events. The aim of this study was to delineate risk factors that increase this risk, as well as to elucidate the risk profile associated with irreversible electroporation in the setting of locally advanced pancreatic adenocarcinoma.A review of our prospective multi-institutional database from December 2015 to March 2022 of patients with locally advanced pancreatic adenocarcinoma who underwent irreversible electroporation was analyzed for adverse events. These were then compared with a control population of patients undergoing pancreatectomy for adenocarcinoma.Adverse events occurred in 51 patients of the 201 patients treated with irreversible electroporation compared with 78 of the 200 patients treated with pancreatectomy. The irreversible electroporation group had a significantly greater incidence of postoperative ascites in stage 3C patients. The most common complications in the irreversible electroporation group were infectious (n = 13), gastrointestinal bleed (n = 11), and ascites (n = 7). Multivariate analysis demonstrated increased risk of severe (grade ≥3) adverse events in the irreversible electroporation cohort who received high dose, neoadjuvant radiation (hazard ratio, 2.4; 95% confidence interval, 1.4-5.4), irreversible electroporation electrodes bracketing the superior mesenteric artery, superior mesenteric vein, and portal venous vein (hazard ratio, 1.9; 95% confidence interval, 1.3-3.4), and who had a bile duct stent in place for >6 months (hazard ratio, 1.7; 95% confidence interval, 1.2-5.6). There were similar rates of 90-day mortality in both groups, irreversible electroporation 2.4% vs pancreatectomy 2.8%.This study revealed a 25% rate of adverse events associated with irreversible electroporation in locally advanced pancreatic adenocarcinoma, which was significantly less (P = .004) than the 39% rate of adverse events associated with pancreatectomy in early-stage disease. Certain unique adverse events in the irreversible electroporation group have been established and should be understood in the care of these patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Cakoibao的应助被小狮子采纳,获得10
1秒前
大个的应助被燕麦片采纳,获得10
1秒前
Nole的应助被开心德地采纳,获得10
1秒前
Gp1983发布了新的文献求助150
1秒前
学术猪八戒完成签到,获得积分10
3秒前
昼屿发布了新的文献求助10
3秒前
美罗培南完成签到 ,获得积分0
3秒前
Nuerrr完成签到 ,获得积分10
3秒前
Jiaqi0315完成签到,获得积分10
4秒前
搜集达人的应助被HaojunWang采纳,获得10
4秒前
6666发布了新的文献求助10
4秒前
_3完成签到,获得积分10
5秒前
深情安青的应助被开心德地采纳,获得10
7秒前
8秒前
9秒前
科研菜鸟完成签到,获得积分10
9秒前
10秒前
贾贡献的应助被ttchen采纳,获得10
10秒前
FashionBoy的应助被开心德地采纳,获得10
13秒前
8787发布了新的文献求助10
14秒前
勤奋仙人掌的应助被渡花采纳,获得10
16秒前
Ava的应助被悦雨采纳,获得10
16秒前
16秒前
晚颜完成签到 ,获得积分10
18秒前
科研通AI6.3的应助被Dyying采纳,获得150
18秒前
星辰大海的应助被开心德地采纳,获得10
19秒前
19秒前
19秒前
20秒前
wrg7409完成签到,获得积分10
23秒前
24秒前
24秒前
扶摇发布了新的文献求助10
24秒前
打打的应助被开心德地采纳,获得10
24秒前
yuki发布了新的文献求助10
26秒前
我要去看星星完成签到 ,获得积分10
27秒前
27秒前
老王发布了新的文献求助10
27秒前
畅沈完成签到 ,获得积分10
28秒前
搜集达人的应助被昼屿采纳,获得10
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188380
求助须知:如何正确求助?哪些是违规求助? 9576202
关于积分的说明 21846057
捐赠科研通 7786438
什么是DOI,文献DOI怎么找? 3435307
关于科研通互助平台的介绍 2559604
邀请新用户注册赠送积分活动 2482312